Amicus Therapeutics Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (37)

Latest Posts

About This Stock More About This Stock
Biotechnology Stocks Preparing A New Bullish Trend
Article By: Taki Tsaklanos
Sunday, July 8, 2018 11:26 AM EST
Biotechnology stocks look bullish, and even more bullish than ever in the last three years.
In this article: IBB, ILMN, REGN, BIIB, CELG, XBI, ARRY, FOLD, SGMO, XLRN
Read
Healthcare Investing Ideas Big And Small
Article By: Marc Lichtenfeld
Monday, January 15, 2018 9:00 PM EST
With a dire need for growth, many in the industry expect the larger biotech and pharmaceutical companies to open their wallets and acquire smaller companies with novel drugs in development.
In this article: BMY, GSK, JNJ, PFE, AVXL, IMMP, BMRN, FOLD, SGEN, MBOT
Read
Top Analysts Are Betting On These 5 Hot Stocks For 2018
Article By: TipRanks
Sunday, October 8, 2017 3:36 PM EST
Biopharma Sarepta Therapeutics is soaring right now, and top analysts are confident that this stock still has further room to grow. Analysts are predicting that Sarepta can climb by a further 29% over the next 12 months.
In this article: GVA, FOLD, AVGO, SRPT, JD
Read
Day Trading Stock Picks For This Week - Tuesday, July 25
Article By: Cory Mitchell, CMT
Tuesday, July 25, 2017 8:27 AM EST
Day trading stock picks likely to move big (up or down) during the week of July 25: HTZ, CBI, WLL, OAS, FOLD, AKS, CLF and AMD.
In this article: HTZ, CBI, WLL, OAS, FOLD, CLF, AKS, AMD Also: SPY, BAC, AAPL, NVDA, BABA, FB, MOMO
Read
Amicus Therapeutics Announces Closing Of Underwritten Offering Of Common Stock
Article By: NASDAQ GlobeNewswire
Tuesday, July 18, 2017 11:18 AM EST
Amicus Therapeutics, a global biotechnology company at the forefront of therapies for rare and orphan diseases, today announced the closing of its previously announced offering of common stock.
In this article: FOLD
Read

PARTNER HEADLINES

Latest Tweets for $FOLD

No tweets yet!